GMGerard Aj Morris

Gerard Aj Morris

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gerard Aj Morris has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Adrian Vella

    Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2XY, UK

    1 shared publication
  • Alex Lam

    Department of Genetics and Genomics, Roslin Institute (Edinburgh), Edinburgh, Midlothian EH25 9PS, UK

    1 shared publication
  • Barry C Healy

    Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, CB2 2XY, UK

    1 shared publication
  • Christopher Lowe

    Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK

    1 shared publication
  • Felicity Payne

    Wellcome Trust Sanger Institute, Hinxton, UK

    1 shared publication
  • Jason D. Cooper

    Department of Medical Genetics, Cambridge Institute for Medical Research, Juvenile Diabetes Research Foundation/ Wellcome Trust Diabetes and Inflammation Laboratory, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK

    1 shared publication

Latest Publications

  • Open Access

    Polymorphism discovery and association analyses of the interferon genes in type 1 diabetes

    by Gerard Aj Morris, Christopher E Lowe, Jason D Cooper, Felicity Payne, Adrian Vella, Lisa Godfrey, John S Hulme, Neil M Walker, Barry C Healy, Alex C Lam, et al.

    Background: The aetiology of the autoimmune disease type 1 diabetes (T1D) involves many genetic and environmental factors. Evidence suggests that innate immune responses, including the action of interferons, may also play a role in the initiation and/or pathogenic process of autoimmunity. In the present report, we have adopted a linkage disequilibrium (LD) mapping approach to test for an association between T1D and three regions encompassing 13 interferon alpha (IFNA) genes, interferon omega-1 (IFNW1), interferon beta-1 (IFNB1), interferon gamma (IFNG) and the interferon consensus-sequence binding protein 1 (ICSBP1). Results: We identified 238 variants, most, single nucleotide polymorphisms (SNPs), by sequencing IFNA, IFNB1, IFNW1 and ICSBP1, 98 of which where novel when compared to dbSNP build 124. We used polymorphisms identified in the SeattleSNP database for INFG. A set of tag SNPs was selected for each of the interferon and interferon-related genes to test for an association between T1D and this complex gene family. A total of 45 tag SNPs were selected and genotyped in a collection of 472 multiplex families. Conclusion: We have developed informative sets of SNPs for the interferon and interferon related genes. No statistical evidence of a major association between T1D and any of the interferon and interferon related genes tested was found.